Influence of hair treatments on detection of antiretrovirals by mass spectrometry imaging.

Autor: Gilliland WM; Department of Chemistry, Furman University, Greenville, South Carolina 29613, USA., White NR, Yam BH, Mwangi JN, Prince HMA, Weideman AM, Kashuba ADM, Rosen EP

Publikováno v: The Analyst [Analyst] 2020 Jul 07; Vol. 145 (13), pp. 4540-4550. Date of Electronic Publication: 2020 May 18.

Population Modeling Highlights Drug Disposition Differences Between Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate in the Blood and Semen.

Autor: Greene SA; University of North Carolina (UNC), UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; SK Life Science, Inc, Fair Lawn, New Jersey, USA., Chen J; University of North Carolina (UNC), UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Merck Co, Philadelphia, Pennsylvania, USA., Prince HMA; UNC School of Medicine, Department of Internal Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Sykes C; University of North Carolina (UNC), UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Schauer AP; University of North Carolina (UNC), UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Blake K; University of North Carolina (UNC), UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Nelson JAE; UNC School of Medicine, Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Gay CL; UNC School of Medicine, Department of Internal Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Cohen MS; UNC School of Medicine, Department of Internal Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Dumond JB; University of North Carolina (UNC), UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Publikováno v: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2019 Oct; Vol. 106 (4), pp. 821-830. Date of Electronic Publication: 2019 May 31.

Heterogeneous antiretroviral drug distribution and HIV/SHIV detection in the gut of three species.

Autor: Thompson CG; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Rosen EP; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Prince HMA; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., White N; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Sykes C; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., de la Cruz G; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Mathews M; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Deleage C; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, USA., Estes JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, USA.; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA., Charlins P; Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA., Mulder LR; Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA., Kovarova M; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Adamson L; Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, Davis, CA, USA., Arora S; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Dellon ES; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Peery AF; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Shaheen NJ; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Gay C; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Muddiman DC; W.M. Keck FTMS Laboratory for Human Health Research, Department of Chemistry, North Carolina State University, Raleigh, NC, USA., Akkina R; Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA., Garcia JV; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Luciw P; Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, Davis, CA, USA., Kashuba ADM; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. akashuba@unc.edu.

Publikováno v: Science translational medicine [Sci Transl Med] 2019 Jul 03; Vol. 11 (499).

Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues.

Autor: Cottrell ML; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Garrett KL; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Prince HMA; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Sykes C; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Schauer A; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Emerson CW; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Peery A; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Rooney JF; Gilead Sciences, Inc., Foster City, CA, USA., McCallister S; Gilead Sciences, Inc., Foster City, CA, USA., Gay C; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Kashuba ADM; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2017 Jun 01; Vol. 72 (6), pp. 1731-1740.